GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tascom Co Ltd (XKRX:336040) » Definitions » EV-to-EBIT

Tascom Co (XKRX:336040) EV-to-EBIT : (As of Oct. 09, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Tascom Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Tascom Co's Enterprise Value is ₩21,424.47 Mil. Tascom Co does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Tascom Co's EV-to-EBIT at this moment.

The historical rank and industry rank for Tascom Co's EV-to-EBIT or its related term are showing as below:

XKRX:336040's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 18.28
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Tascom Co's Enterprise Value for the quarter that ended in . 20 was ₩0.00 Mil. Tascom Co does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Tascom Co's Earnings Yield (Joel Greenblatt) % at this moment.


Tascom Co EV-to-EBIT Historical Data

The historical data trend for Tascom Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tascom Co EV-to-EBIT Chart

Tascom Co Annual Data
Trend
EV-to-EBIT

Tascom Co Semi-Annual Data
EV-to-EBIT

Competitive Comparison of Tascom Co's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Tascom Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tascom Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tascom Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Tascom Co's EV-to-EBIT falls into.



Tascom Co EV-to-EBIT Calculation

Tascom Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=21424.468/
=


Tascom Co  (XKRX:336040) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Tascom Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: . 20 ) =EBIT / Enterprise Value (Q: . 20 )
=/
= %


Tascom Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Tascom Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Tascom Co Business Description

Traded in Other Exchanges
N/A
Address
43 BanPo-daero 28-gil, 5th Floor, i-SENS Building, SeoCho-gu, Seoul, KOR
Tascom Co Ltd, formerly YIDOBIO Inc is a diabetes specialty company in Korea. The company develop cell therapy for the treatment of diabetes. It also manufactures and distributes diabetic supplies. The company's products include Blood glucose measurement system-acuraview, BD Ultra Fine PRO Pen Needle, Syringes-BD Ultrafine Syringes, Ido Sharp Container, and Ido safety lancet.

Tascom Co Headlines

No Headlines